Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.
about
Genome-Wide Association Study in Immunocompetent Patients with Delayed Hypersensitivity to Sulfonamide AntimicrobialsImmunological features of Pneumocystis carinii infection in humans.Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.Diagnosis of allergic reactions to sulfonamides.Allergic reactions to drugs: involvement of T cellsCombination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy miceAllergic adverse reactions to sulfonamides.Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.Hypersensitivity reactions to HIV therapy.Monitoring of co-trimoxazole concentrations in serum during treatment of pneumocystis carinii pneumonia.A Suspected Case of Efavirenz-Induced Stevens-Johnson Syndrome.Immune response to sulfamethoxazole in patients with AIDS.Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infectionPredicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary Pneumocystis carinii pneumonia prophylaxis.In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV.T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction.Role of T cells in drug allergies.Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection.N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus.RNA expression profiling in sulfamethoxazole-treated patients with a range of in vitro lymphocyte cytotoxicity phenotypes.
P2860
Q28550088-12903CE1-533F-4ECD-8D38-A167A6CFA466Q33538931-ED3270D6-0FB0-4C28-8ACB-1558F4792617Q33777950-91937706-5ABA-4A69-885A-A7B11F7FFAA1Q33874332-99DF80BE-B0BB-4021-925B-480C408318B1Q34036255-C15E16A9-D52F-47CA-91BF-6A8CC5FDC844Q34429315-136EF85C-D455-416F-BA56-E1E75CA8F764Q34564723-C7E23F7D-D4C4-435D-8431-57727A47F43EQ34830063-AA8B4E02-8588-4B4D-9D46-683515C69187Q34976463-C8EAE208-8ED5-47E9-8085-E08F17BFAF3CQ35120725-37CEFFC5-440E-49F8-B510-EF32AC243062Q37218913-41BAC0DE-62AB-4564-9452-667C60F1C93BQ39809588-D0D5A796-0712-4C3F-857D-D6D7A888D538Q40502992-22739EE1-4715-4706-BE15-EB162BA55C33Q40683534-9E1FFB86-621A-4318-83B7-4C2209D4C535Q40711577-B6E40A71-D86F-45DF-9F09-4DFB5DACCDD0Q40993397-70E3F858-4F3A-412A-BEF9-41E4DD075F3AQ41738597-5ECD05D5-FCD0-4C51-9353-683975EE2299Q42496178-B7875794-1140-4252-A3E4-163CD9223FEBQ44542833-5A5E59E2-1E14-4910-9EAC-3CD9590C1284Q55068342-9BFD4AEE-8F9E-4E28-BE2C-0063EB34DA6E
P2860
Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Clinical and laboratory marker ...... is carinii pneumonia and AIDS.
@en
Clinical and laboratory marker ...... is carinii pneumonia and AIDS.
@nl
type
label
Clinical and laboratory marker ...... is carinii pneumonia and AIDS.
@en
Clinical and laboratory marker ...... is carinii pneumonia and AIDS.
@nl
prefLabel
Clinical and laboratory marker ...... is carinii pneumonia and AIDS.
@en
Clinical and laboratory marker ...... is carinii pneumonia and AIDS.
@nl
P2093
P921
P356
P1476
Clinical and laboratory marker ...... is carinii pneumonia and AIDS.
@en
P2093
P304
P356
10.1093/INFDIS/167.1.180
P407
P577
1993-01-01T00:00:00Z